Managing bone pathology is more complex in CKD patients compared to the general population of the same age because of abnormalities in calcium, phosphorus, PTH, and vitamin D, with epiphenomena including vascular and soft tissue calcifications and alterations in bone physiology, turnover, and mineralization [13]. This evidence concerns the gene PTH and chronic kidney disease.